LILY34:BVMF
Eli Lilly And Company BDR
R$205,49
arrow_downward
-0,56%(-1,16) 1D
30 ກ.ຍ., 10 ໂມງ 54 ນາທີ 55 ວິນາທີ GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Open
R$206,65
High
R$206,65
Low
R$204,14
Mkt. cap
1,12 ລ້ານລ້ານ
Avg. vol.
38,66 ພັນ
Volume
1,52 ພັນ
52-wk high
R$223,07
52-wk low
R$133,92
Shares outstanding
941,36 ລ້ານ
No. of employees
50 ພັນ
Open
R$206,65
High
R$206,65
Low
R$204,14
Mkt. cap
1,12 ລ້ານລ້ານ
Avg. vol.
38,66 ພັນ
Volume
1,52 ພັນ
52-wk high
R$223,07
52-wk low
R$133,92
Shares outstanding
941,36 ລ້ານ
No. of employees
50 ພັນ
News stories
From web sources and news partners
Yahoo! Finance Canada
·
1 ຊົ່ວໂມງກ່ອນ
Can Novo's Licensing Strategy Build Its Next Wave of Oral Medicines?
Investing.com Canada
·
1 ຊົ່ວໂມງກ່ອນ
Lilly’s Ebglyss shows efficacy in hand, foot dermatitis trial By Investing.com
The Business Journals
·
4 ຊົ່ວໂມງກ່ອນ
Portal Innovations CEO John Flavin expects more pharma acquisitions of Houston companies
MSN
·
12 ຊົ່ວໂມງກ່ອນ
Opinion: Eli Lilly stock is a no-brainer pick to buy on the dip
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50 ພັນ
Founded1876
Headquartersອິນເດຍນາໂພລິສ, ອິນເດຍນາ, ສະຫະລັດ
SectorPharmaceutical industry
Websitelilly.com